The abnormal production of tissue inhibitor of matrix metalloproteinases type 2 (TIMP2) might repair myocardial functions which resulted in cardiac hypertrophy (Fan et al., 2019). This evidence concerns the gene TIMP2 and cardiac hypertrophy.